Position in HIMS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$15,034,952
+$14,830,456 QoQ
Shares Held
724,227
+11399.3% QoQ
Ownership
0.313%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
19 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Derivatives in HIMS
reported options exposure · as of Dec 31, 2024CallValue
$0
CallShares
0
PutValue
$8,518,614
PutShares
352,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MARSHALL WACE, LLP holds $558,161,566 across 33 Drug Manufacturers - Specialty & Generic names. HIMS ranks #13 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
9,349,817 | $126,316,026 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
508,977 | $67,052,628 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
611,747 | $46,401,008 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
75,977 | $45,052,841 | |
| 5 | RDY |
Dr Reddys Laboratories Ltd
|
2,664,306 | $36,900,638 | |
| 6 | ALKS |
Alkermes plc.
|
999,322 | $35,336,024 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
1,382,412 | $33,081,118 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
748,812 | $24,763,212 |
All Filings in HIMS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,034,952 | 724,227 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $204,496 | 6,298 | Shares | Other | 2026-02-13 | |
| 2025-06-30 | $5,256,682 | 105,450 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $7,738,317 | 261,872 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $8,518,614 | 352,300 | Put | Other | 2025-02-13 | |
| 2024-12-31 | $1,040,417 | 43,028 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $29,755,170 | 1,615,373 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $44,538,211 | 2,205,954 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $87,254,357 | 5,640,230 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $46,898,398 | 5,269,483 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $38,845,090 | 6,175,690 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $55,233,149 | 5,875,867 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $39,391,694 | 3,970,937 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $28,761,912 | 4,487,038 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $12,557,392 | 2,250,429 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $9,719,988 | 2,145,693 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $5,649,570 | 1,059,957 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $60,351 | 9,214 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $420,294 | 55,742 | Shares | Sole | 2021-11-15 | |
| 2020-12-31 | $2,724,579 | 186,615 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||